🇺🇸 FDA
Pipeline program

0.33% ropivacaine 250ml

local anaesthetic

Approved small_molecule completed

Quick answer

0.33% ropivacaine 250ml for Pain is a Approved program (small_molecule) at Guangzhou General Hospital of Guangzhou Military Command with 1 ClinicalTrials.gov record(s).

Program details

Company
Guangzhou General Hospital of Guangzhou Military Command
Indication
Pain
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials